Radiation-induced Angiosarcoma as a Cause of Pleural Effusion.

  title={Radiation-induced Angiosarcoma as a Cause of Pleural Effusion.},
  author={Russell J. Miller and Lakshmi Mudambi and Macarena R Vial and Neda Kalhor and Horiana B Grosu},
  journal={American journal of respiratory and critical care medicine},
  volume={196 4},
Spontaneous synchronous bilateral hemothorax as the only finding in primary pleural angiosarcoma: a case report and a literature review.
The case of a 55-year-old man who referred to the authors' hospital for a spontaneous bilateral hemothorax, deceased from hemorrhagic shock ten days later and the diagnosis of primary pleural epithelioid angiosarcoma was obtained only by autopsy is presented. Expand
Angiosarcoma: a review of diagnosis and current treatment.
The goal of this review is to summarize the current data regarding of angiosarcoma and its clinical presentation and management, providing a useful clinical tool to explore the optimal treatment. Expand
The Diagnosis of Pleural Tumors Other Than Mesothelioma.
A review of those diverse tumors that can involve the pleura other than mesothelioma in order to facilitate their accurate diagnosis is provided. Expand


Systemic Treatment Options for Radiation-Associated Sarcomas
  • M. Dickson
  • Medicine
  • Current Treatment Options in Oncology
  • 2014
Patients with radiation-associated sarcomas may have received prior anthracyclines to treat antecedent malignancies such as breast cancer or lymphoma, and if additional doxorubicin cannot be used, liposomal doxorbicin is a reasonable substitute. Expand
Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations
RAS is a rare event in BRCA carriers as in the general population, and should not be considered in the decision regarding irradiation treatment in this population. Expand
Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival?
The poor prognosis of RIS patients are not due to the previous radiotherapy per se, but related to the unfavourable factors – central tumour site, incomplete surgical remission, microscopic tumour necrosis and the presence of metastases, the two former factors overrepresented in RIS. Expand
Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?
  • R. Gladdy, L. Qin, +5 authors S. Singer
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2010
DSS in patients with primary RAS is significantly worse compared with sporadic STS independent of sarcoma histologic type, and margin status, and tumor size are the most important independent predictors of DSS in Patients with RASs. Expand
Sarcoma after radiation therapy: retrospective multiinstitutional study of 80 histologically confirmed cases. Radiation Therapist and Pathologist Groups of the Fédération Nationale des Centres de Lutte Contre le Cancer.
The results confirm the beneficial effect of surgery in sarcoma treatment and further study is needed to explore the roles of combined treatments. Expand
Postirradiation sarcomas. A single‐institution study and review of the literature
The authors undertook a study to estimate the risk, and compared the risk of postirradiation sarcoma (PIS) with other treatment modalities used against cancer. Expand